Earnings calendar/GRCE
Grace Therapeutics, Inc. (GRCE)
Next report date and post-earnings actuals — standardized metrics from the filed statements. No analyst estimates, no narrative, no price targets.
Pre-earnings
The next report date (from the company's filing cadence) and how the business has been running.
Next report
Nov 12, 2026
Expected from filing cadence
EPS target
$-0.15
Estimates not sourced
Revenue target
$1.0M
Estimates not sourced
Trailing EPS (avg 4Q)
$-0.30
Beat rate last 4: 50%
Latest EPS YoY
-333.3%
vs 2025-08-12
Latest revenue YoY
—
How results look so far
Trailing revenue (avg 4Q)
$0
Printed quarters
EPS beat rate (4Q)
50%
Share of quarters that beat EPS est.
Post-earnings
Did the company hit the target? Actual vs estimate and surprise.
Last print
Aug 13, 2026
EPS miss
EPS actual / est
$-0.91 / $-0.13
-603.8%
Revenue actual / est
$0 / $400,000
-100.0%
Result
Below target
EPS vs prior estimate, when one exists
Earnings history
Estimate vs actual and surprise % by print date
| Date | EPS est | EPS act | EPS surprise | Rev est | Rev act | Rev surprise |
|---|---|---|---|---|---|---|
| 11/12/2026upcoming | $-0.15 | Pending | — | $1.0M | Pending | — |
| 8/13/2026 | $-0.13 | $-0.91 | -603.8% | $400,000 | $0 | -100.0% |
| 6/22/2026upcoming | $-0.24 | Pending | — | $900,000 | Pending | — |
| 6/18/2026 | $-0.24 | $-0.07 | +70.8% | $900,000 | Pending | — |
| 2/12/2026 | $-0.09 | $-0.14 | -55.6% | — | Pending | — |
| 11/13/2025 | $-0.12 | $-0.08 | +31.5% | — | Pending | — |
| 8/12/2025 | $-0.22 | $-0.21 | +4.5% | — | Pending | — |
| 6/23/2025 | $-0.20 | $0.10 | +150.0% | — | Pending | — |
| 2/13/2025 | $-0.24 | $-0.26 | -8.3% | — | Pending | — |
| 11/13/2024 | $-0.33 | $-0.33 | 0.0% | — | Pending | — |
| 8/9/2024 | $-0.27 | $-0.24 | +9.4% | — | Pending | — |
| 6/21/2024 | $-0.35 | $-0.17 | +51.4% | — | Pending | — |
| 2/12/2024 | $-0.23 | $-0.21 | +8.7% | — | Pending | — |
| 11/13/2023 | $-0.26 | $-0.43 | -65.4% | — | Pending | — |
| 8/11/2023 | $-0.28 | $-0.54 | -92.9% | — | Pending | — |
| 6/23/2023 | $-0.84 | $-3.90 | -364.3% | — | Pending | — |
| 2/14/2023 | $-0.74 | $-0.54 | +27.0% | — | Pending | — |
| 11/14/2022 | — | $-0.66 | — | — | Pending | — |
| 8/11/2022 | — | $-0.79 | — | — | Pending | — |
| 6/21/2022 | — | $-0.72 | — | — | Pending | — |
| 2/14/2022 | — | $-0.65 | — | — | Pending | — |
| 11/10/2021 | — | $0.14 | — | — | Pending | — |
| 8/12/2021 | — | $-0.58 | — | — | Pending | — |
| 6/22/2021 | — | $-1.32 | — | — | $91,495.15 | — |
| 2/9/2021 | — | $-1.21 | — | — | $63,451.35 | — |
| 11/16/2020 | — | $-2.33 | — | — | Pending | — |
| 8/13/2020 | — | $-1.82 | — | — | Pending | — |
| 6/30/2020 | — | $6.67 | — | — | Pending | — |
| 12/31/2019 | — | $-5.04 | — | — | Pending | — |
| 9/30/2019 | — | $-9.18 | — | — | Pending | — |
| 6/30/2019 | — | $-4.11 | — | — | Pending | — |
| 6/26/2019 | — | $-7.07 | — | — | Pending | — |
| 12/31/2018 | — | $-1.82 | — | — | Pending | — |
| 9/30/2018 | — | $-17.77 | — | — | Pending | — |
| 6/30/2018 | — | $-6.42 | — | — | Pending | — |
| 6/29/2018 | — | $-9.09 | — | — | Pending | — |
| 3/31/2018 | — | $-11.43 | — | — | Pending | — |
| 12/31/2017 | — | $-11.98 | — | — | Pending | — |
| 9/30/2017 | — | $-9.51 | — | — | Pending | — |
| 6/30/2017 | — | $-5.35 | — | — | Pending | — |
| 11/30/2016 | — | $-5.99 | — | — | $701.3 | — |
| 8/31/2016 | — | $-6.11 | — | — | Pending | — |
| 5/31/2016 | — | $-8.32 | — | — | $1,700.02 | — |
| 11/30/2015 | — | $-5.52 | — | — | $2,835.79 | — |
| 8/31/2015 | — | $-3.19 | — | — | $3,988.65 | — |
| 6/17/2015 | — | $-6.84 | — | — | $108,466.53 | — |
| 5/31/2015 | — | $-2.81 | — | — | $3,329.43 | — |
| 11/30/2014 | — | $10.41 | — | — | $22,220.38 | — |
| 8/31/2014 | — | $-14.17 | — | — | $6,369.73 | — |
| 6/6/2014 | — | $-8.61 | — | — | $150,193.66 | — |
| 5/31/2014 | — | $5.17 | — | — | $47,573.01 | — |
| 11/30/2013 | — | $-19.59 | — | — | $25,195.14 | — |
| 8/31/2013 | — | $-18.21 | — | — | $239,871.42 | — |
| 5/31/2013 | — | $-12.10 | — | — | $5,994.35 | — |
| 5/30/2013 | — | $-11.30 | — | — | $26,834.57 | — |
| 11/30/2012 | — | $-10.76 | — | — | $429,740.76 | — |
| 8/31/2012 | — | $-11.78 | — | — | $241,513.5 | — |
| 5/31/2012 | — | $-9.77 | — | — | $12,822.03 | — |
| 2/29/2012 | — | $-12.06 | — | — | $14,952.82 | — |
| 11/30/2011 | — | $-14.43 | — | — | Pending | — |
| 8/31/2011 | — | $-13.36 | — | — | Pending | — |
| 5/31/2011 | — | $-8.06 | — | — | $87,021.06 | — |
| 2/28/2011 | — | $-8.63 | — | — | $29,827.81 | — |
| 11/30/2010 | — | $-5.85 | — | — | Pending | — |
| 8/31/2010 | — | $-6.32 | — | — | Pending | — |
| 5/31/2010 | — | $-4.91 | — | — | Pending | — |
| 2/28/2010 | — | $-8.38 | — | — | Pending | — |
| 11/30/2009 | — | $-6.67 | — | — | Pending | — |
| 8/31/2009 | — | $-22.34 | — | — | Pending | — |
| 5/31/2009 | — | $-13.03 | — | — | Pending | — |
| 11/30/2008 | — | $-92.92 | — | — | Pending | — |
Need GRCE data in your own agent or pipeline?
The earnings data on this page — report dates, filed EPS/revenue actuals and run-rate history — is also available programmatically through the EvidInvest MCP server & financial data API for Claude, Cursor, or any MCP client and HTTP pipeline.